Summary of findings: leflunomide + methotrexate vs methotrexate
Withdrawals due to adverse events · patients with rheumatoid arthritis in adults
1 finding from 1 review
- no estimate extracted1 study · 263 participantsModerate
The review found no eligible studies for this question.
Summary of findings: leflunomide + methotrexate leads to higher ACR 50 at 6 months compared with methotrexate, 6 months (high certainty).